These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 19243046

  • 1. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE, Hutchinson CE, Buckley DL.
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 3. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW.
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Rudolph B, Rehbein H, Staack A, Taupitz M, Prochnow D, Beyersdorff D.
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [Abstract] [Full Text] [Related]

  • 5. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
    Welsch GH, Mamisch TC, Hughes T, Zilkens C, Quirbach S, Scheffler K, Kraff O, Schweitzer ME, Szomolanyi P, Trattnig S.
    Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
    [Abstract] [Full Text] [Related]

  • 6. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S, Baghi M, Wagenblast J, Bisdas T, Thng CH, Mack MG, Koh TS, Ernemann U.
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [Abstract] [Full Text] [Related]

  • 7. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis.
    Bisdas S, Baghi M, Wagenblast J, Vogl TJ, Thng CH, Koh TS.
    J Magn Reson Imaging; 2008 May; 27(5):963-9. PubMed ID: 18407543
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases.
    Takeda T, Takeda A, Nagaoka T, Kunieda E, Takemasa K, Watanabe M, Hatou T, Oguro S, Katayama M.
    Acta Radiol; 2008 Dec; 49(10):1167-73. PubMed ID: 18979271
    [Abstract] [Full Text] [Related]

  • 10. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.
    Ren J, Huan Y, Wang H, Chang YJ, Zhao HT, Ge YL, Liu Y, Yang Y.
    Clin Radiol; 2008 Feb; 63(2):153-9. PubMed ID: 18194690
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O, Lüdemann L, Prochnow D, Abramjuk C, Taupitz M, Hamm B, Beyersdorff D.
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [Abstract] [Full Text] [Related]

  • 12. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
    Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA, de la Rosette JJ, Blickman JG, Barentsz JO.
    Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA, Cutajar M, Gordon I.
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer.
    Eyal E, Bloch BN, Rofsky NM, Furman-Haran E, Genega EM, Lenkinski RE, Degani H.
    Invest Radiol; 2010 Apr; 45(4):174-81. PubMed ID: 20177391
    [Abstract] [Full Text] [Related]

  • 17. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
    Zelhof B, Lowry M, Rodrigues G, Kraus S, Turnbull L.
    BJU Int; 2009 Sep; 104(5):621-7. PubMed ID: 19281464
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M, Chaudhari AR, Bailey KL, Aref S, Wiener EC.
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [Abstract] [Full Text] [Related]

  • 20. Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weighted MRI.
    Vos PC, Hambrock T, Barenstz JO, Huisman HJ.
    Phys Med Biol; 2010 Mar 21; 55(6):1719-34. PubMed ID: 20197602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.